Literature DB >> 29554589

Conditional gene knockout and reconstitution in human iPSCs with an inducible Cas9 system.

Mengyao Wu1, Senquan Liu2, Yongxing Gao2, Hao Bai2, Vasiliki Machairaki3, Gang Li4, Tong Chen5, Linzhao Cheng6.   

Abstract

Precise genome editing in human induced pluripotent stem cells (iPSCs) significantly enhances our capability to use human iPSCs for disease modeling, drug testing and screening as well as investigation of human cell biology. In this study, we seek to achieve conditional expression of the CD55 gene in order to interrogate its functions. We used two human iPSC lines that have unique genotypes, and constructed an inducible Cas9 gene expression system that is integrated at the AAVS1 safe harbor site in the human genome. Using paired guide RNAs, we observed efficient knock-out with an intended deletion in the coding region of several genes including CD55 and ETV6 genes. This paired guide RNA approach enabled us to efficiently identify homozygous iPSC clones with an intended deletion. Once an iPSC clone lacking CD55 expression was identified and characterized, we were able to use the same doxycycline system to induce expression of a CD55 transgene from a piggyBac vector, in both undifferentiated and differentiated iPSCs. This single cell line of gene knock-out complemented with an inducible transgene is sufficient to achieve conditional expression of the CD55 gene. The methodology described here is broadly applicable to other genes in order to interrogate their functions.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29554589     DOI: 10.1016/j.scr.2018.03.003

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  6 in total

1.  Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.

Authors:  D Lansing Taylor; Albert Gough; Mark E Schurdak; Lawrence Vernetti; Chakra S Chennubhotla; Daniel Lefever; Fen Pei; James R Faeder; Timothy R Lezon; Andrew M Stern; Ivet Bahar
Journal:  Handb Exp Pharmacol       Date:  2019

Review 2.  Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity.

Authors:  Emily A Pinheiro; Tarek Magdy; Paul W Burridge
Journal:  J Cardiovasc Transl Res       Date:  2020-02-20       Impact factor: 4.132

Review 3.  hiPSCs in cardio-oncology: deciphering the genomics.

Authors:  Emily A Pinheiro; K Ashley Fetterman; Paul W Burridge
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

4.  Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics.

Authors:  Christopher H Hulton; Emily A Costa; Nisargbhai S Shah; Alvaro Quintanal-Villalonga; Glenn Heller; Elisa de Stanchina; Charles M Rudin; John T Poirier
Journal:  Nat Cancer       Date:  2020-03-09

5.  Improving the efficiency of gene insertion in a human artificial chromosome vector and its transfer in human-induced pluripotent stem cells.

Authors:  Yoshinori Hasegawa; Masashi Ikeno; Nobutaka Suzuki; Manabu Nakayama; Osamu Ohara
Journal:  Biol Methods Protoc       Date:  2018-12-31

6.  BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.

Authors:  Senquan Liu; Mengyao Wu; Moira Lancelot; Jiusheng Deng; Yongxing Gao; John D Roback; Tong Chen; Linzhao Cheng
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.